University of Notre Dame
Department of Chemical and Biomolecular Engineering
The Bilgicer Group
R
ESEARCH
P
EOPLE
C
OURSES
P
UBLICATIONS
I
N THE NEWS
C
OLLABORATORS
U
SEFUL LINKS
C
ONTACT US
I
n
T
he
N
ews
2016
ABC57 News :
One Notre Dame team is facing a different opponent--allergies
University of Notre Dame, What Would You Fight For? :
Fighting to Cure Food Allergies
South Bend Tribune :
Cancer treatment system wins Notre Dame contest
Notre Dame News :
AD&T Supported Researchers Improve Drug Delivery, Spur Commercial Activity
Molecular Cancer Therapeutics Highlights :
Synergistic Dual Drug Liposomes in Multiple Myeloma
Notre Dame News :
Taking Multiple Myeloma Down for the Count
Precision Medicine News :
Students Pitch Nanoparticle Research at Business Plan Competition
Inside Indiana Business :
Student Startup Builds ‘Bubbles’ to Deliver Cancer Drugs
Notre Dame News :
Cancer treatment system wins 2016 McCloskey Business Plan Competition
2014
South Bend Tribune :
Touched by the Kelly Cares Foundation
Living Without Magazine :
Anaphylaxis Treatment
WLBT - MS News Now :
Loyola, Notre Dame Join Forces Against Cancer
2013
Immunotherapy :
New therapeutic could help prevent hypersensitive allergic reactions
Peanut Allergy.com :
Scientists getting closer to new treatment for allergies
Inside Indiana Business :
Notre Dame Researcher Aims to Block Dangerous Food Allergies
Nature Chemical Biology News And Views :
Immunology: Allergy's Achilles' heel?
Nature SciBX (Science-Business eXchange) :
IgE - Indication : Allergy
WNDU-TV Maureen's Medical Moment :
Peanut and Deadly Allergies: Notre Dame research aims to prevent
Babble by Disney :
A Cure for Food Allergies?
Science Daily :
Progress Toward Treatment for Dangerous Allergies
The Observer :
Professor Researches Potential Allergy Treatment
Medical News Today :
Making Progress Toward a Treatment for Dangerous Allergies
Notre Dame News :
Notre Dame Researchers Make Progress Toward a Treatment for Dangerous Allergies
Notre Dame College of Engineering News :
Notre Dame Researchers Make Progress Toward a Treatment for Dangerous Allergies
Harper Cancer Research Institute News :
Bilgicer Receives Leukemia Research Foundation Award
HemOnc Today :
Nanoparticles offer ‘infinite’ possibilities for cancer treatment
ACS Nano :
Perspective - Design Principles for Clinical Efficacy of Cancer Nanomedicine: A Look into the Basics
Advanced Diagnostics and Therapeutics :
Designing more effective cancer treatments
2012
Global Medical Discovery :
Small-Molecule-Based Affinity Chromatography Method for Antibody Purification via Nucleotide Binding Site Targeting
Faculty of 1000 :
Small-Molecule-Based Affinity Chromatography Method for Antibody Purification via Nucleotide Binding Site Targeting
Indiana Clinical and Translational Sciences Institute :
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Expert Review of Hematology :
Engineered Nanoparticles may Improve Multiple Myeloma Treatment
Nanomedicine :
Engineered Nanoparticles may Improve Multiple Myeloma Treatment
Materials Today :
Designer Nanoparticles to Treat Blood Cancer
C&EN News :
Method Better Pins Down Antibodies
Genetic Engineering & Biotechnology News :
Nanoparticle Delivers Chemotherapy Directly to Multiple Myeloma and Prevents CAM-DR
Notre Dame College of Engineering News :
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Notre Dame News :
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
The Scientist :
Pure Pursuits: Techniques for simpler, cheaper, and better antibody purification
The Economic Times :
An end to allergies: New drug could block reactions to anything from pollen to penicillin
BBC Knowledge :
An end to allergies?
(
p
df)
2011
Nature SciBX :
Heterobivalent IgE ligands for the treatment and prevention of allergy
Coping with Allergies & Asthma :
Researchers Engineer a New Way to Inhibit Allergic Reactions Without Side Effects
AAAS Science Update :
Pre-empting Allergies
Medical News Today :
A New Way Engineered To Inhibit Allergic Reactions Without Side Effects
Next Big Future :
Researchers engineer new way to inhibit allergic reactions without side effects
Science Daily :
Inhibiting Allergic Reactions Without Side Effects
R&D Magazine :
Researchers engineer new way to inhibit allergic reactions without side effects
BioQuick News :
Breakthrough Approach to Allergy Treatment
Notre Dame News :
Researchers engineer new way to inhibit allergic reactions without side effects
Amplitude :
Focus On Biomedical Engineering
2010
Fox 28 :
Grants awarded for Indiana based initiatives
South Bend Tribune :
Researcher Bilgicer using nanotechnology to improve cancer treatment
Notre Dame Magazine :
Smart drugs target disease
Notre Dame News :
Notre Dame researchers receive medical technologies grants for Indiana-based initiatives
Scope IU School of Medicine Newsletter :
Indiana CTSI Grants
Harvard Gazette :
Using nanotechnology to improve a cancer treatment
Harvard Gazette :
Improving a cancer drug
Indian Express : From an old anti-cancer drug, new hope
AD&T News :
AD&T scientist among Notre Dame researchers receiving medical technologies grants
The Bilgicer Group, 231 McCourtney Hall, Notre Dame, IN 46556 | Phone: 574.631.3411 | Updated: September 29, 2016